Tokyo, Japan

Masamitsu Iino

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masamitsu Iino. Retrieved from https://idiyas.com/inventor/masamitsu-iino-9hgc6jct

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masamitsu Iino: Innovator in Inositol Receptor Ligands

Introduction: Masamitsu Iino is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with inositol receptors. His work has implications for various biological processes and potential therapeutic applications.

Latest Patents: Masamitsu Iino holds a patent for Ip3 receptor ligands. The patent describes a compound represented by the general formula (I) or a salt thereof. In this formula, R represents a group defined by specific alkyl and amino structures, while X represents an anion. This compound is useful as a ligand for inositol-1,4,5-trisphosphate (IP3) receptors, which play a crucial role in cellular signaling.

Career Highlights: Throughout his career, Masamitsu Iino has focused on innovative research that bridges chemistry and biology. His work has led to advancements in understanding how certain compounds can modulate receptor activity, which is vital for developing new therapeutic strategies.

Collaborations: Masamitsu Iino has collaborated with notable colleagues, including Tetsuo Nagano and Kazuya Kikuchi. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion: Masamitsu Iino's contributions to the field of biochemistry, particularly through his patent on Ip3 receptor ligands, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications related to cellular signaling.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…